Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Feature</td><td class="align_center">Sequences</td><td class="align_center">OR (95% CI)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Wavelet-HLH_firstorder_kurtosis</td><td class="align_center">T1WI</td><td class="align_center">0.448 (0.229 -0.877)</td></tr><tr><td class="align_left">Wavelet-HLH_glcm_correlation</td><td class="align_center">T1WI</td><td class="align_center">3.784 (1.818 7.876)</td></tr><tr><td class="align_left">Wavelet-HHL_firstorder_kurtosis</td><td class="align_center">T2WI</td><td class="align_center">2.842 (1.328 6.081)</td></tr><tr><td class="align_left">Wavelet-LLH_firstorder_mean</td><td class="align_center">T2WI</td><td class="align_center">4.340 (1.538 12.244)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>glcm: gray level cooccurrence matrix; OR: odds ratio; CI: confidence interval.<br/></div></td></tr></table>

<div>Selected radiomics features and their odds ratio.</div>

BioMed Research International

tab2

Table 2

Table 2: Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma 

Table 2 | Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma 